AllianceBernstein’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,350,456
| Closed | -$63.5M | – | 3300 |
|
|
2025
Q2 | $63.5M | Buy |
1,350,456
+1,253,369
| +1,291% | +$55.8M | 0.02% | 547 |
|
|
2025
Q1 | $4.28M | Buy |
97,087
+20,656
| +27% | +$951K | ﹤0.01% | 1502 |
|
|
2024
Q4 | $2.76M | Sell |
76,431
-74,390
| -49% | -$2.6M | ﹤0.01% | 1794 |
|
|
2024
Q3 | $4.83M | Buy |
150,821
+10,579
| +8% | +$395K | ﹤0.01% | 1526 |
|
|
2024
Q2 | $5.28M | Buy |
140,242
+70,712
| +102% | +$2.98M | ﹤0.01% | 1462 |
|
|
2024
Q1 | $3.42M | Buy |
69,530
+3,140
| +5% | +$145K | ﹤0.01% | 1630 |
|
|
2023
Q4 | $2.42M | Hold |
66,390
| – | – | ﹤0.01% | 1832 |
|
|
2023
Q3 | $1.53M | Hold |
66,390
| – | – | ﹤0.01% | 2020 |
|
|
2023
Q2 | $1.74M | Buy |
66,390
+30,690
| +86% | +$806K | ﹤0.01% | 1983 |
|
|
2023
Q1 | $919K | Hold |
35,700
| – | – | ﹤0.01% | 2274 |
|
|
2022
Q4 | $929K | Hold |
35,700
| – | – | ﹤0.01% | 2323 |
|
|
2022
Q3 | $1.02M | Hold |
35,700
| – | – | ﹤0.01% | 2281 |
|
|
2022
Q2 | $879K | Buy |
35,700
+1,000
| +3% | +$36.6K | ﹤0.01% | 2416 |
|
|
2022
Q1 | $1.96M | Buy |
34,700
+100
| +0.3% | +$5.72K | ﹤0.01% | 2104 |
|
|
2021
Q4 | $2.15M | Buy |
34,600
+400
| +1% | +$26.5K | ﹤0.01% | 2101 |
|
|
2021
Q3 | $2.17M | Sell |
34,200
-2,000
| -6% | -$154K | ﹤0.01% | 2120 |
|
|
2021
Q2 | $2.98M | Buy |
36,200
+2,000
| +6% | +$152K | ﹤0.01% | 1939 |
|
|
2021
Q1 | $2.52M | Buy |
34,200
+600
| +2% | +$47K | ﹤0.01% | 1961 |
|
|
2020
Q4 | $2.44M | Buy |
33,600
+4,000
| +14% | +$257K | ﹤0.01% | 1860 |
|
|
2020
Q3 | $1.41M | Buy |
29,600
+1,600
| +6% | +$68.1K | ﹤0.01% | 2030 |
|
|
2020
Q2 | $1.18M | Buy |
28,000
+16,900
| +152% | +$601K | ﹤0.01% | 2122 |
|
|
2020
Q1 | $300K | Buy |
+11,100
| New | +$362K | ﹤0.01% | 2621 |
|
Other funds holding SWTX
AllianceBernstein's SWTX Position: Q3 2025 in Review
AllianceBernstein sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 1,350,456 shares — an estimated $63.5M sold.
AllianceBernstein first reported a position in SWTX in Q1 2020 and held it in 22 quarters. The position peaked at $63.5M in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.
- AllianceBernstein reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
- AllianceBernstein sold 1,350,456 SpringWorks Therapeutics shares in Q3 2025, an estimated $63.5M.
- AllianceBernstein first reported a position in SpringWorks Therapeutics in Q1 2020 and held it in 22 quarters.
- AllianceBernstein's SpringWorks Therapeutics position peaked at $63.5M in Q2 2025.
- 3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.
Based on AllianceBernstein's 13F filing for Q3 2025, filed 14 Nov 2025.